Comparing Efficacy of Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation With Conventional Chemo-(Immuno) Therapy in Patients With Relapsed or Refractory CLL: A Markov Decision Analysis
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.71
Full Text
Open PDFAbstract
Available in full text
Date
May 7, 2012
Authors
Publisher
Springer Science and Business Media LLC